CNO Financial Group, Inc., through its subsidiaries, develops, markets, and administers health insurance, annuity, individual life insurance, insurance products, and financial services for middle-income pre-retiree and retired Americans in the United States. It offers Medicare supplement, supplemental health, and long-term care insurance policies; life insurance; and annuities, as well as Medicare advantage plans to individual consumers through phone, virtually, online, and face-to-face with agents. The company also focuses on sale of voluntary benefit life and health insurance products for businesses, associations, and other membership groups by interacting with customers at their place of employment. In addition, it provides fixed indexed annuities; fixed interest annuities, including fixed rate single and flexible premium deferred annuities; single premium immediate annuities; supplemental health products, such as specified disease, accident, and hospital indemnity products; and long-term care plans primarily to retirees, lesser degree, and older self-employed individuals in the middle-income market. Further, the company offers universal life and other interest-sensitive life products; and traditional life policies that include whole life, graded benefit life, term life, and single premium whole life products, as well as graded benefit life insurance products. It markets its products under the Bankers Life, Washington National, and Colonial Penn brand names. The company was founded in 1979 and is headquartered in Carmel, Indiana.
Analyst Perspectives | Explore varied analyst views, with price targets ranging from $29 to $38, reflecting confidence in CNO's growth potential and strategic positioning in the insurance secto |
Market Valuation | CNO shares trade at 0.9x book value, an attractive valuation compared to life insurance peers at 1.2-1.4x, despite recent underperformance against the S&P 1500 Life & Health index |
Strategic Expansion | Delve into CNO's establishment of CNO Bermuda, a move aimed at enhancing liability management and exploring new growth avenues in a favorable regulatory environment |
Financial Resilience | CNO's Q2 2024 results surpassed estimates, leading to upward revision of full-year EPS guidance, driven by robust segment performance and investment income growth |
Metrics to compare | CNO | Sector Sector - Average of metrics from a broad group of related Financials sector companies | Relationship RelationshipCNOPeersSector | |
---|---|---|---|---|
P/E Ratio | 12.0x | 7.5x | 9.5x | |
PEG Ratio | −0.77 | 0.28 | 0.03 | |
Price / Book | 1.4x | 1.1x | 1.0x | |
Price / LTM Sales | 0.9x | 0.9x | 2.8x | |
Upside (Analyst Target) | 14.3% | 9.6% | 8.7% | |
Fair Value Upside | Unlock | 3.4% | 1.1% | Unlock |